Jay Luly; President, Chief Executive Officer, Director; Enanta Pharmaceuticals Inc Paul Mellett; Chief Financial and Administrative Officer; Enanta Pharmaceuticals Inc Tara Kieffer; Chief Product ...
The ENT disorder treatment includes a variety of medications, including nasal steroids, nasal decongestant sprays, oral and topical antihistamines, and nasal saline washes. Additionally, a variety of ...
The current market research report delves into the demand dynamics of the Drug-Induced Cardiotoxicity industry across various segments, offering insights into its size, share, growth trajectory, ...
The global contraceptives market witnessed substantial growth, valued at $26,321.5 million in 2020 and projected to reach $50,595.8 million by 2030, with a CAGR of 6.5% from 2020 to 2030. This report ...
As BioNTech continues to endure a sharp decline in COVID-19 vaccine sales, the German mRNA specialist is looking ahead to the ...
Over 13,000 Americans have reported negative effects on their health after getting a Covid shot, but say the federal government is ignoring their pleas for help.
Benefits of Covid vaccines war outweigh risks. Pandemic has created ethical dilemmas. The way court's resolve them could impact people's perception of vaccines ...
Sales of Spikevax, the Cambridge company’s only marketed product, plummeted to $167 million from $1.9 billion, the firm ...
Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings expectations. Reported EPS is $0.82, expectations ...
A new meta-analysis of 16 studies reveals that, for pre-exposure prophylactic vaccination (PrEP, which is used for disease ...
GSK’s total sales increased 10% in the first quarter of 2024 compared to the same period last year, thanks in large part to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback